Researchers have found that a family history of alcoholism affects a process that the brain uses when transitioning from a mentally demanding state to
a resting state.
Researchers have discovered that a material shaped like a one-dimensional DNA helix might further push the limits on a transistor’s size. The material comes from a rare earth element called tellurium.
Purdue University scientists, led by Humaira Gowher, an associate professor in the Department of Biochemistry, have discovered the epigenetic process that keeps stem cell enhancers in active, primed or repressed states. In particular, her team has identified a protein-protein interaction that blocks proper formation of these states.
Researchers have developed software that reduces space taken up by apps on a smartphone, allowing users to continue downloading the apps they want without deleting some first.
Researchers from Purdue University created a portable device that works with smartphones and laptops to do on-site testing for
E. coli in food samples.
The human-made chemicals that make our kitchen pans stick-free, our athletic wear water-repellent and firefighting chemicals more efficient do their jobs incredibly well, but it’s at the expense of lingering in the body and environment for what is believed to be forever.
Almost 80,000 dogs have been nominated to participate in a new nationwide study on dog aging.
Purdue University has been awarded a $5.9 million contract from the Air Force Research Laboratory to develop the first quiet Mach 8 wind tunnel in the world, further solidifying the state of Indiana’s major role in one of the U.S. Department of Defense’s top technological priorities – the development of hypersonics systems.
Recipients of Purdue AG-celerator fall investments are VinSense, a company assisting in wine grape agriculture through Purdue-patented technology, and Karysoft, a genomics data analytics
company empowering biologists for rapid data mining through just a few clicks proprietary
platform to accelerate innovations.
PhysIQ, founded by Purdue alumnus Gary Conkright, received a $500,000 investment from Purdue Research Foundation’s Foundry Investment Fund to help advance medical technology.